Laparoscopic partial nephrectomy for centrally located renal tumors

NewsGuard 100/100 Score

The Cleveland Clinic Group has shown that with experience they have been able to effectively offer laparoscopic partial nephrectomy (LPN) to more patients with centrally located lesions.

They found that these tumors were significantly larger than those in patients undergoing LPN for peripheral tumors, and required repair of the pelvicaliceal system and sutured hemostatic renal parenchyma re-approximation.

However when compared to patients with peripheral tumors, the central tumor LPN group had similar blood loss, equivalent positive margin rate (1 per group), similar median postoperative serum creatinine, and comparable intraoperative and late postoperative complications.

While the central tumors required significantly longer warm ischemia time (33.5 vs. 30 minutes), operative time (3.5 vs. 3 hours), and longer hospital stays (67 vs. 60 hours), compared to the peripheral group, these were not clinically significant.

However, the early positive complications, notably bleeding and urine leakage, occurred more often in the central tumor group (6% vs. 2% p = 0.05).

Therefore in view of the previous LPN paper and these clinical results, it may be reasonable for the experienced laparoscopist to expand laparoscopic partial nephrectomy to central lesions > 4 cm in size.

By Elspeth M. McDougall, MD


Reference:

Journal Urology 175; 849-852, March 2006

http://www.ncbi.nlm.nih.gov/entrez/

Frank I, Colombo JR Jr, Rubinstein M, Desai M, Kaouk J, Gill IS.

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Prostaglandin E2: The culprit behind tumor immune evasion